Teva Pharmaceutical Industries - TEVA - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Teva Pharmaceutical Industries - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
TEVA	New York	2834	http://www.tevapharm.com/	39.1913 -0.2987
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Teva Pharmaceutical Industries Will Twice Be Nice For The Israel ETF? - May 23rd, 2013 8:28 am 4 Big Drug Companies With Big Juicy Yields - May 22nd, 2013 1:51 pm Why Momenta Offers A Unique Opportunity In The Pharmaceutical Industry - May 22nd, 2013 10:56 am Teva Pharmaceutical Industries Ltd Stock Hold Recommendation Reiterated (TEVA) - May 21st, 2013 8:00 am A New Drug Sales Model - May 20th, 2013 1:15 pm Ireland Welcomes Watson Pharmaceuticals, an American Success - May 20th, 2013 12:27 pm Is There a Bubble Brewing? - May 20th, 2013 9:54 am Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pill - May 20th, 2013 9:30 am Israel seeks to rein in company tax breaks - May 20th, 2013 8:07 am A Broad Look At Teva's Pipeline - May 20th, 2013 5:46 am SmithOnStocks Opines On Stocks: May 19th Edition - May 19th, 2013 6:32 pm Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started - May 19th, 2013 12:00 pm Statin Users May Have a Reason to Rejoice After This Data - May 19th, 2013 10:05 am Good News For Health Care Stocks Part 2 - May 17th, 2013 9:50 am Billionaire Frost Props Up Prolor Bid With Stock Buys - May 16th, 2013 3:01 pm Antares: Reiteration Of My Buy Recommendation - May 16th, 2013 12:01 pm Finny Kuruvilla, Portfolio Manager of the Eventide Gilead Fund, Interviews with The Wall Street Transcript: Investing in Health Care Innovation - May 16th, 2013 11:23 am 4 Stocks Improving Performance Of The Health Care Sector - May 16th, 2013 11:03 am Following Up an Acquisition With an Even Larger Merger? - May 16th, 2013 9:20 am 3 Stocks to Get on Your Watchlist - May 15th, 2013 8:45 am View All Current Headlines >>